Niger FY2020 Work Plan
Download:

The FY2020 work plan outlines the activities that are expected to be undertaken in Niger in the next fiscal year through USAID's Act to End NTDs | West program (Act | West), managed by FHI 360 and implemented in Niger by Helen Keller International. 

In Niger, the national NTD program is comprised of three disease-specific programs:

  • National Program for the Elimination of Onchocerciasis and Lymphatic Filariasis (Programme National de Dévolution de l'Onchocercose et d'Elimination de la Filariose Lymphatique or PNDO/EFL)
  • National Schistosomiasis and Soil-Transmitted Helminthiasis Control Program (Programme National de Lutte contre la Bilharziose et les Géohelminthes or PNLBG)
  • National Eye Health Program (Programme Nationale de Santé Oculaire or PNSO).

These three programs are unified by the overarching coordination structure, the Program for Control of Neglected Tropical Diseases (Programme National de Lutte contre les MTN or PNLMTN), which is situated within the Direction des Etudes et de la Programmation (DEP) of the Ministry of Public Health (MoPH).

USAID’s Act to End Neglected Tropical Diseases | West program (2019-2023) currently supports the three specific NTD programs (PNLBG, PNSO, and PNDO/EFL), and the overarching coordination structure (PNLMTN) to implement integrated NTD activities throughout the country. The main activities include mass treatments, capacity building, social mobilization, training, advocacy, supply chain management, and monitoring and evaluation. Funding is also provided through Act | West to the Pharmacy and Laboratory Directorate (Direction des Pharmacies et Laboratoires) and National Office of Pharmaceutical and Chemical Products (Office National des Produits Pharmaceutiques et Chimiques) for drug quality and management.

Niger FY2020 Act to End NTDs | West Program Work Plan
Type
Work Plan
Year of publication
Disease
All Preventive Chemotherapy NTDs
Country
All Countries, Niger
Focus Areas
Mass Drug Administration (MDA), MDA implementation, Community outreach, Drug procurement & supply chain support, Cross-border initiatives, Annual training for MDA, Support for NTD Sustainability, Advocacy and policies, Cross-sector collaboration, NTD governance, Strategic health information, NTD Capacity Building, Monitoring, Evaluation, Research, Learning and Adapting (MERLA), Disease-specific assessments, post-treatment surveillance, and related training, Disease & morbidity mapping & assessment, Learning & quality improvement, Data for decision-making, Operational research, Dossier development
Partners
FHI360, Helen Keller International